Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Flunixin Meglumine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis method for flunixin meglumine reduces energy and cost. Reliable veterinary drugs supplier offering high purity and scalable production solutions.
Advanced synthesis of flunixin meglumine intermediate via high-pressure fluorination. Delivers high purity and scalable manufacturing for veterinary pharmaceuticals.
Patent CN104193674B details a low-temperature phase-transfer catalytic route for flunixin meglumine, offering enhanced purity and streamlined manufacturing for veterinary pharmaceutical supply chains.
Novel synthetic route for flunixin meglumine intermediate using p-toluenesulfonic acid. High yield, cost-effective, scalable process for veterinary pharmaceutical manufacturing.
Patent CN103694167A details a high-yield synthesis of Flunixin Meglumine using a novel CuO/TsOH dual-catalyst system in water, offering significant cost and purity advantages for veterinary pharmaceutical manufacturers.
Patent CN114890902B details a safer, two-step synthesis for 2-methyl-3-trifluoromethyl aniline, offering significant cost reduction in API manufacturing.